rolipram has been researched along with Atrial Fibrillation in 1 studies
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abella, LMR | 3 |
| Hoffmann, R | 3 |
| Neumann, J | 3 |
| Hofmann, B | 3 |
| Gergs, U | 3 |
1 other study available for rolipram and Atrial Fibrillation
| Article | Year |
|---|---|
Levosimendan increases the phosphorylation state of phospholamban in the isolated human atrium.
Topics: Animals; Atrial Fibrillation; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Huma | 2023 |
Levosimendan increases the phosphorylation state of phospholamban in the isolated human atrium.
Topics: Animals; Atrial Fibrillation; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Huma | 2023 |
Levosimendan increases the phosphorylation state of phospholamban in the isolated human atrium.
Topics: Animals; Atrial Fibrillation; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Huma | 2023 |
Levosimendan increases the phosphorylation state of phospholamban in the isolated human atrium.
Topics: Animals; Atrial Fibrillation; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Huma | 2023 |